IJS Global GEFCO UK has been granted a Wholesale Dealer Authorisation (WDA) by the UK Regulatory Body, the MHRA, for its operations at the London Heathrow site with immediate effect. Good Distribution Practice (GDP) status was also awarded to IJS Global GEFCO NL in April this year, and shows that the company fulfils strict pharmaceutical requirements of the European Commission and the World Health Organization.
“In an increasingly demanding environment for distribution of medicinal products, obtaining a WDA reconfirms our commitment to offering the highest possible quality standards in support of our customers’ evolving requirements,” said Josette Wells, Director – Quality and Compliance, IJS Global GEFCO UK. “This licence is another step forward in our drive to establish an enhanced services platform for the Life Sciences and Healthcare industry.”
Internationally accepted GDP guidelines play a key role in assuring the transport and distribution of medicinal products for human use does not adversely impact product quality and integrity. IJS Global GEFCO’s operations in the Netherlands already have WDA certification. Both countries are now able to store medicinal products in full compliance of EU regulations.